Why Metabolic Health Is a Common Thread Across Diabetes, Heart Disease, and Some Cancer
A common mechanism for reversing metabolic disease in some patients seems to be the sustained flattening of the hills and valleys of glucose and insulin.
AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds
AstraZeneca’s deal with CSPC Pharmaceutical Group includes a Phase 1-ready obesity drug that hits the same targets as Eli Lilly’s obesity drug Zepbound, but with monthly dosing. The new collaboration builds on an existing drug R&D relationship between the two companies.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
The CGM Adoption Gap Is Worse Than You Think
A new study found that continuous glucose monitors can cut healthcare costs by about 20% while also improving outcomes for insulin-dependent diabetes patients, largely by reducing hospitalizations and emergency department visits. Despite these benefits and broad insurance coverage, roughly 80% of eligible patients still are not using the technology — highlighting a significant adoption gap.
HealthTap Joins LillyDirect to Expand Access to Primary Care–Led Diabetes Treatment
HealthTap is now offering virtual primary care for patients with diabetes on LillyDirect, becoming the platform’s first primary care provider.
Over-the-Counter CGMs Are Here — But Do They Really Make Sense for Non-Diabetics?
Over-the-counter continuous glucose monitors have been available for people with and without diabetes for more than a year now — but the data they collect doesn’t seem to be as useful for nondiabetic users, according to new research from Mass General Brigham.
The Future of Glucose Monitoring: Why Blood-Based Measurements Matter
Today, people living with diabetes have several ways of monitoring glucose levels, whether through finger pricks or CGMs. Both ways of measuring glucose levels have benefits and limitations.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Priority Health Teams Up with Virta Health for Diabetes, Weight Loss Support
Priority Health has partnered with Virta Health to offer a suite of diabetes and weight management solutions to its employer clients.
Why Is Medtronic Spinning Off Its Diabetes Business?
Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market.
Aeroflow Health Unveils New Diabetes Management Program
Aeroflow Health has launched a new diabetes program that offers educational content on diabetes management, medical nutrition therapy and more.
The Role of Medication Delivery in Non-Adherence
For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023
Medicare Part D spending on 10 diabetes drugs increased 364% between 2019 and 2023.
Prioritizing CKD Screening Guidelines is Imperative to Combat Global Health Crisis
The consequences for not prioritizing new guidelines for CKD screening have a devastating impact on population health by increasing the global mortality rate and driving higher healthcare costs.
Food as Health: Shifting from Treatment to Prevention of Diet-Related Disease
Overcoming the systemic, structural and cultural issues that lead to poor nutrition is complex, making it even more essential for both private and public investment in food as health programs and policies that have been shown to be effective.
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender
Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics.
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the company’s Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach.